These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 38098243)
1. PDCD4 and MIR-21 are promising biomarkers in the follow-up of OED in liquid biopsies. Arslan Bozdag L; Açik L; Ersoy HE; Bayir Ö; Korkmaz MH; Mollaoglu N; Gultekin SE Oral Dis; 2024 Sep; 30(6):3873-3883. PubMed ID: 38098243 [TBL] [Abstract][Full Text] [Related]
2. Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma. Reis PP; Tomenson M; Cervigne NK; Machado J; Jurisica I; Pintilie M; Sukhai MA; Perez-Ordonez B; Grénman R; Gilbert RW; Gullane PJ; Irish JC; Kamel-Reid S Mol Cancer; 2010 Sep; 9():238. PubMed ID: 20831814 [TBL] [Abstract][Full Text] [Related]
3. Clinical value and potential circulating of miR-99a as tumor suppressor biomarker in serum of oral squamous cell carcinoma and erosive atrophic lichen planus. Farshbaf A; Mohtasham N; Shamshiri AK; Khazaeni K; Aghaee-Bakhtiari SH; Arab F; Cheshomi M; Hassanabadi M; Mohajertehran F J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101806. PubMed ID: 38408642 [TBL] [Abstract][Full Text] [Related]
4. Unveiling the Potential of Serum MiR-483-5p: A Promising Diagnostic and Prognostic Biomarker in OLP and OSCC Patients by Soltaninezhad P; Arab F; Mohtasham N; FakherBaheri M; Kavishahi NN; Aghaee-Bakhtiari SH; Zare-Mahmoodabadi R; Pakfetrat A; Taban KI; Mohajertehran F Curr Pharm Des; 2024; 30(4):310-322. PubMed ID: 38310566 [TBL] [Abstract][Full Text] [Related]
5. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma. Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632 [TBL] [Abstract][Full Text] [Related]
6. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma. Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584 [TBL] [Abstract][Full Text] [Related]
7. Chang C; Wang H; Liu J; Pan C; Zhang D; Li X; Pan Y ACS Infect Dis; 2019 Aug; 5(8):1336-1347. PubMed ID: 31243990 [TBL] [Abstract][Full Text] [Related]
8. Effects of MicroRNA-499 On the Inflammatory Damage of Endothelial Cells During Coronary Artery Disease Via the Targeting of PDCD4 Through the NF-Κβ/TNF-α Signaling Pathway. Zhang YH; He K; Shi G Cell Physiol Biochem; 2017; 44(1):110-124. PubMed ID: 29131009 [TBL] [Abstract][Full Text] [Related]
9. Identification of salivary metabolites for oral squamous cell carcinoma and oral epithelial dysplasia screening from persistent suspicious oral mucosal lesions. Ishikawa S; Wong DTW; Sugimoto M; Gleber-Netto FO; Li F; Tu M; Zhang Y; Akin D; Iino M Clin Oral Investig; 2019 Sep; 23(9):3557-3563. PubMed ID: 30539290 [TBL] [Abstract][Full Text] [Related]
11. Biomarkers for Oral Squamous Cell Carcinoma (miR-24, miR-200, and miR-34): Screening and Detection MicroRNA. Bahrami N; Pirrafiee M; Azadi F; Azimnejad R; Fotook Kiaei SZ; Abbasi AJ; Kazempour Dizaji M; Lookzadeh S; Nejatollahi SMR; Daustani M; Dargahi H; Mohamadnia A Asian Pac J Cancer Prev; 2024 Jul; 25(7):2265-2269. PubMed ID: 39068557 [TBL] [Abstract][Full Text] [Related]
12. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients. Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794 [TBL] [Abstract][Full Text] [Related]
13. Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma. Singh P; Srivastava AN; Sharma R; Mateen S; Shukla B; Singh A; Chandel S Asian Pac J Cancer Prev; 2018 Apr; 19(4):1053-1057. PubMed ID: 29699056 [TBL] [Abstract][Full Text] [Related]
14. A Noninvasive Test for MicroRNA Expression in Oral Squamous Cell Carcinoma. Gissi DB; Morandi L; Gabusi A; Tarsitano A; Marchetti C; Cura F; Palmieri A; Montebugnoli L; Asioli S; Foschini MP; Scapoli L Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914173 [TBL] [Abstract][Full Text] [Related]
15. miR-208a-3p suppresses cell apoptosis by targeting PDCD4 in gastric cancer. Yin K; Liu M; Zhang M; Wang F; Fen M; Liu Z; Yuan Y; Gao S; Yang L; Zhang W; Zhang J; Guo B; Xu J; Liang H; Chen X; Guan W Oncotarget; 2016 Oct; 7(41):67321-67332. PubMed ID: 27634902 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma. Chen L; Hu J; Pan L; Yin X; Wang Q; Chen H Cancer Biomark; 2018; 23(3):333-339. PubMed ID: 30223386 [TBL] [Abstract][Full Text] [Related]
17. Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma. Ren W; Qiang C; Gao L; Li SM; Zhang LM; Wang XL; Dong JW; Chen C; Liu CY; Zhi KQ Biomarkers; 2014 Nov; 19(7):590-6. PubMed ID: 25174622 [TBL] [Abstract][Full Text] [Related]
18. Higher expression of whole blood microRNA-21 in patients with ankylosing spondylitis associated with programmed cell death 4 mRNA expression and collagen cross-linked C-telopeptide concentration. Huang CH; Wei JC; Chang WC; Chiou SY; Chou CH; Lin YJ; Hung PH; Wong RH J Rheumatol; 2014 Jun; 41(6):1104-11. PubMed ID: 24786924 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-183 promotes proliferation and invasion in oesophageal squamous cell carcinoma by targeting programmed cell death 4. Ren LH; Chen WX; Li S; He XY; Zhang ZM; Li M; Cao RS; Hao B; Zhang HJ; Qiu HQ; Shi RH Br J Cancer; 2014 Nov; 111(10):2003-13. PubMed ID: 25211657 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis. Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]